首页> 外文期刊>Canadian Respiratory Journal >Clinical and Functional Characteristics of Subjects with Asthma, COPD, and Asthma-COPD Overlap: A Multicentre Study in Vietnam
【24h】

Clinical and Functional Characteristics of Subjects with Asthma, COPD, and Asthma-COPD Overlap: A Multicentre Study in Vietnam

机译:哮喘,COPD和哮喘-COPD重叠受试者的临床和功能特征:越南的多中心研究

获取原文
           

摘要

Introduction. Subjects with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) share common features of patients with asthma and COPD. Our study was planned to describe the clinical and functional features of subjects with ACO compared to asthma and COPD patients. Subjects and Methods. Study subjects who met the inclusion criteria were classified into three different groups asthma, COPD, and ACO groups. All study subjects underwent clinical examination and biological and functional testing. They were then followed for 6 months to evaluate the response to conventional treatment. Results. From March 2015 to March 2017, 76 asthmatic (mean age 41?±?22 years), 74 COPD (59?±?13 years), and 59 ACO (52?±?14 years) subjects were included. The percentage of subjects with dyspnea on excretion in the ACO group was higher than that in asthma and COPD groups ( and , resp.). Subjects with COPD and ACO had significant airflow limitation (FEV1) compared to asthma (64?±?17% and 54?±?14% versus 80?±?22%; and , resp.). The levels of FENO in subjects with asthma and ACO were significantly higher than those in subjects with COPD (46?±?28?ppb and 34?±?12?ppb versus 15?±?8?ppb; and , resp.). VO2 max and 6MWD were improved in study subjects after 6 months of treatment. Increased CANO and AHI??15/hour had a significant probability of risk for ACO (OR?=?33.2, , and OR?=?3.4, , resp.). Conclusion. Subjects with ACO share the common clinical and functional characteristics of asthma and COPD but are more likely to have sleep apnea. The majority of patients with ACO have a favourable response to combined treatment.
机译:介绍。哮喘与慢性阻塞性肺疾病(COPD)重叠(ACO)的受试者具有哮喘和COPD患者的共同特征。我们的研究计划描述与哮喘和COPD患者相比,ACO患者的临床和功能特征。主题和方法。符合入选标准的研究对象分为哮喘,COPD和ACO三组。所有研究对象均经过临床检查以及生物学和功能测试。然后随访6个月,以评估对常规治疗的反应。结果。从2015年3月到2017年3月,纳入了76名哮喘患者(平均年龄41±±22岁),74名COPD(59±±13岁)和59名ACO(52±±14岁)。 ACO组排泄困难的患者百分比高于哮喘组和COPD组(和)。与哮喘相比,患有COPD和ACO的受试者的气流受限(FEV1)显着(分别为64%±17%和54%±14%,而80%±22%;和)。哮喘和ACO患者的FENO水平显着高于COPD患者(46?±?28?ppb和34?±?12?ppb对比15?±?8?ppb;及)。治疗6个月后,研究对象的VO2 max和6MWD有所改善。 CANO和AHI?>?15 /小时的增加有很大的ACO风险(OR?=?33.2,和OR?=?3.4,分别)。结论。患有ACO的受试者具有哮喘和COPD的共同临床和功能特征,但更容易出现睡眠呼吸暂停。大多数ACO患者对联合治疗有良好的反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号